Funder: National Institutes of Health (NIH)
Due Dates: January 25, 2027
Funding Amounts: Estimated total program funding: $25,000,000; approximately 12 awards; typical project period up to 5 years.
Summary: Supports translational research centers (SPOREs) focused on prevention, detection, diagnosis, and treatment of organ-specific or mechanistically related human cancers.
Key Information: Clinical trial required; forecasted opportunity—dates subject to change.